iifl-logo

Procter & Gamble Health Ltd Share Price Live

Add as a Preferred Source on Google
₹5,299
(-1.05%)
May 11, 2026|04:24:51 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹5,315
  • Day's High₹5,355
  • 52 Wk High₹6,739
  • Prev. Close₹5,355
  • Day's Low₹5,247.5
  • 52 Wk Low ₹4,707
  • Turnover (lac)174.39
  • P/E30.27
  • Face Value₹10
  • Book Value₹463.43
  • EPS176.81
  • Mkt. Cap (Cr.)₹8,796.01
  • Div. Yield2.34
View All Historical Data

No Record Found

No Record Found

Procter & Gamble Health Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹5,315

Prev. Close

₹5,355

Turnover(Lac.)

₹174.39

Day's High

₹5,355

Day's Low

₹5,247.5

52 Week's High

₹6,739

52 Week's Low

₹4,707

Book Value

₹463.43

Face Value

₹10

Mkt Cap (₹ Cr.)

8,796.01

P/E

30.27

EPS

176.81

Divi. Yield

2.34

Procter & Gamble Health Ltd Corporate Action

6 Aug 2025

12:00 AM

AGM

Announcement Date: 06 Aug, 2025

arrow

22 Aug 2024

12:00 AM

BookCloser

arrow

26 Dec 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

6 Feb 2026

12:00 AM

Dividend

Dividend Amount: 110

Record Date: 12 Feb, 2026

arrow

Procter & Gamble Health Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Procter & Gamble Health Ltd SHAREHOLDING SNAPSHOT

11 May, 2026|04:20 PM
Mar-2026Dec-2025Sep-2025Jun-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 51.81%

Foreign: 51.81%

Indian: 0.00%

Non-Promoter- 19.87%

Institutions: 19.87%

Non-Institutions: 28.31%

Custodian: 0.00%

Read More
Share PriceShare Price

Procter & Gamble Health Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Jun-2024Jun-2023Jun-2022

Equity Capital

16.6

16.6

16.6

16.6

Preference Capital

0

0

0

0

Reserves

520.36

521.64

734.29

599.89

Net Worth

536.96

538.24

750.89

616.49

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Jun-2021Jun-2020Dec-2017Dec-2016

Revenue

1,008.73

1,355.86

1,103.96

992.56

yoy growth (%)

-25.6

22.81

11.22

5.64

Raw materials

-314.82

-431.44

-441.09

-411.54

As % of sales

31.2

31.82

39.95

41.46

Employee costs

-150.47

-182.93

-169.64

-154.23

View Profit & Loss
Y/e 31 Mar( In .Cr)Jun-2021Jun-2020Dec-2017Dec-2016

Profit before tax

233.28

354.85

135.19

115.17

Depreciation

-30.04

-29.45

-26.4

-24.81

Tax paid

-56.48

-100.77

-58.28

-36.04

Working capital

-233.3

269.12

35.2

57.07

Other operating items

View Cash Flow
Y/e 31 MarJun-2021Jun-2020Dec-2017Dec-2016

Growth matrix (%)

Revenue growth

-25.6

22.81

11.22

5.64

Op profit growth

-21.99

129.18

19.07

38.5

EBIT growth

-34.03

162.48

17.38

38.2

Net profit growth

-30.41

170.55

18.67

47.74

View Ratios

No Record Found

Procter & Gamble Health Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,847.9

101.564,43,229.15705.440.875,651.2199.24

Divis Laboratories Ltd

DIVISLAB

6,710.5

69.231,78,100.225980.452,578578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,380.8

66.381,48,250.955770.142,547249.82

Cipla Ltd

CIPLA

1,347

23.761,08,864.87616.881.194,256.93411.55

Lupin Ltd

LUPIN

2,379.5

18.031,08,721.362,163.690.765,152.26659.07

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Procter & Gamble Health Ltd

Management

Register Office

Registrar Office

Managing Director

Milind Thatte

Non Executive Director

Aalok Agrawal

Chairperson

S Madhavan

Non Executive Director

Seema Sambasivan

Independent Director

Krishna Sarma

Independent Director

SHARAD TYAGI

Company Sec. & Compli. Officer

Zeal Rupani

Additional Director & CFO

Shashank Srowthy

Registered Office

Godrej One 8th Floor,

Projshanagar Vikhroli (East),

Maharashtra - 400079

Tel: 91-22-62109000

Website: http://www.pghealthindia.com

Email: investorgrievance.im@pg.com

Registrar Office

Karvy Selenium Tow-B,

31&32 Financial Dist, Nanakramguda,

Hyderabad-500032

Tel: 91-40-67162222

Website: www.kfintech.com

Email: einward.ris@karvy.com

Summary

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967. The Companys name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002. Later, the...
Read More

Reports by Procter & Gamble Health Ltd

Company FAQs

What is the Procter & Gamble Health Ltd share price today?

The Procter & Gamble Health Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹5299 today.

What is the Market Cap of Procter & Gamble Health Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Procter & Gamble Health Ltd is ₹8796.01 Cr. as of 11 May ‘26

What is the PE and PB ratio of Procter & Gamble Health Ltd?

The PE and PB ratios of Procter & Gamble Health Ltd is 30.27 and 14.33 as of 11 May ‘26

What is the 52 Week High and Low of Procter & Gamble Health Ltd?

The 52-week high/low is the highest and lowest price at which a Procter & Gamble Health Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Procter & Gamble Health Ltd is ₹4707 and ₹6739 as of 11 May ‘26

What is the CAGR of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd's CAGR for 5 Years at -1.74%, 3 Years at 4.33%, 1 Year at 6.59%, 6 Month at -9.86%, 3 Month at -0.46% and 1 Month at 10.56%.

What is the shareholding pattern of Procter & Gamble Health Ltd?

The shareholding pattern of Procter & Gamble Health Ltd is as follows:
Promoters - 51.82 %
Institutions - 19.87 %
Public - 28.31 %

QUICKLINKS FOR Procter & Gamble Health Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.